These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 11462067)

  • 61. [The prognostic effect of natural killer cell infiltration to tumoral tissues in stage I non-small cell lung cancer].
    Karadayi S; Kayi Cangir A; Ozturk S; Dizbay Sak S; Akal M; Akay H
    Tuberk Toraks; 2008; 56(3):251-6. PubMed ID: 18932025
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Node-negative non-small cell lung cancer: pathological staging and survival in 1765 consecutive cases.
    Robinson BM; Kennedy C; McLean J; McCaughan BC
    J Thorac Oncol; 2011 Oct; 6(10):1691-6. PubMed ID: 21869717
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Predictive clinical outcome of the intratumoral CD66b-positive neutrophil-to-CD8-positive T-cell ratio in patients with resectable nonsmall cell lung cancer.
    Ilie M; Hofman V; Ortholan C; Bonnetaud C; Coëlle C; Mouroux J; Hofman P
    Cancer; 2012 Mar; 118(6):1726-37. PubMed ID: 21953630
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Prognostic value of visceral pleural invasion in non-small cell lung cancer: A propensity score matching study based on the SEER registry.
    Yang X; Sun F; Chen L; Shi M; Shi Y; Lin Z; Feng M; Zhan C; Jiang W; Wang Q
    J Surg Oncol; 2017 Sep; 116(3):398-406. PubMed ID: 28543219
    [TBL] [Abstract][Full Text] [Related]  

  • 65. The impact of superior mediastinal lymph node metastases on prognosis in non-small cell lung cancer located in the right middle lobe.
    Sakao Y; Okumura S; Mingyon M; Uehara H; Ishikawa Y; Nakagawa K
    J Thorac Oncol; 2011 Mar; 6(3):494-9. PubMed ID: 21266920
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Phosphorylated Akt expression is a prognostic marker in early-stage non-small cell lung cancer.
    Yip PY; Cooper WA; Kohonen-Corish MR; Lin BP; McCaughan BC; Boyer MJ; Kench JG; Horvath LG
    J Clin Pathol; 2014 Apr; 67(4):333-40. PubMed ID: 24265323
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Predictive relevance of PD-L1 expression combined with CD8+ TIL density in stage III non-small cell lung cancer patients receiving concurrent chemoradiotherapy.
    Tokito T; Azuma K; Kawahara A; Ishii H; Yamada K; Matsuo N; Kinoshita T; Mizukami N; Ono H; Kage M; Hoshino T
    Eur J Cancer; 2016 Mar; 55():7-14. PubMed ID: 26771872
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Age, tumor size, type of surgery, and gender predict survival in early stage (stage I and II) non-small cell lung cancer after surgical resection.
    Agarwal M; Brahmanday G; Chmielewski GW; Welsh RJ; Ravikrishnan KP
    Lung Cancer; 2010 Jun; 68(3):398-402. PubMed ID: 19762109
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Preresection serum C-reactive protein measurement and survival among patients with resectable non-small cell lung cancer.
    Alifano M; Falcoz PE; Seegers V; Roche N; Schussler O; Younes M; Antonacci F; Forgez P; Dechartres A; Massard G; Damotte D; Régnard JF
    J Thorac Cardiovasc Surg; 2011 Nov; 142(5):1161-7. PubMed ID: 21872279
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab.
    Diem S; Schmid S; Krapf M; Flatz L; Born D; Jochum W; Templeton AJ; Früh M
    Lung Cancer; 2017 Sep; 111():176-181. PubMed ID: 28838390
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Inflammation-based scoring is a useful prognostic predictor of pulmonary resection for elderly patients with clinical stage I non-small-cell lung cancer.
    Miyazaki T; Yamasaki N; Tsuchiya T; Matsumoto K; Kunizaki M; Taniguchi D; Nagayasu T
    Eur J Cardiothorac Surg; 2015 Apr; 47(4):e140-5. PubMed ID: 25548132
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Clinical application value of prognostic nutritional index for predicting survival in patients with advanced non-small cell lung cancer].
    Xu WJ; Kang YM; Zhou L; Chen FF; Song YH; Zhang CQ
    Zhonghua Zhong Liu Za Zhi; 2017 Feb; 39(2):146-149. PubMed ID: 28219213
    [No Abstract]   [Full Text] [Related]  

  • 73. The favorable prognostic significance of atelectasis in patients with advanced non-small cell lung cancer: results of a prospective observational study.
    Dediu M; Crisan E; Radut M; Tarlea A; Median D; Alexandru A; Vremes G; Gal C
    Lung Cancer; 2009 Feb; 63(2):271-6. PubMed ID: 18565617
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Visceral pleural invasion remains a size-independent prognostic factor in stage I non-small cell lung cancer.
    Huang H; Wang T; Hu B; Pan C
    Ann Thorac Surg; 2015 Apr; 99(4):1130-9. PubMed ID: 25704861
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Pulmonary resection in patients aged 80 years or over with clinical stage I non-small cell lung cancer: prognostic factors for overall survival and risk factors for postoperative complications.
    Okami J; Higashiyama M; Asamura H; Goya T; Koshiishi Y; Sohara Y; Eguchi K; Mori M; Nakanishi Y; Tsuchiya R; Miyaoka E;
    J Thorac Oncol; 2009 Oct; 4(10):1247-53. PubMed ID: 19609223
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Recurrence patterns in patients with early stage non-small cell lung cancers undergoing positive pleural lavage cytology.
    Satoh Y; Hoshi R; Ishikawa Y; Horai T; Okumura S; Nakagawa K
    Ann Thorac Surg; 2007 Jan; 83(1):197-202. PubMed ID: 17184661
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Impact of prognostic factors on endpoints for clinical studies.
    Sørensen JB
    Lung Cancer; 1994 Nov; 11 Suppl 3():S45-54. PubMed ID: 7704512
    [No Abstract]   [Full Text] [Related]  

  • 78. The role of inflammation in the pathogenesis of non-small cell lung cancer.
    O'Callaghan DS; O'Donnell D; O'Connell F; O'Byrne KJ
    J Thorac Oncol; 2010 Dec; 5(12):2024-36. PubMed ID: 21155185
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Prognostic tests in cancer of the lung: fact and fallacy.
    Braeman J
    Med Hypotheses; 1975; 1(5):176-7. PubMed ID: 1214675
    [No Abstract]   [Full Text] [Related]  

  • 80. Lung T-cell subset composition at the time of surgical resection is a prognostic indicator in non-small cell lung cancer.
    Zikos TA; Donnenberg AD; Landreneau RJ; Luketich JD; Donnenberg VS
    Cancer Immunol Immunother; 2011 Jun; 60(6):819-27. PubMed ID: 21373990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.